Immunocore Holdings plc (IMCR) DCF Valuation

Immunocore Holdings plc (IMCR) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Immunocore Holdings plc (IMCR) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Gain insight into your Immunocore Holdings plc (IMCR) valuation analysis using our sophisticated DCF Calculator! This Excel template comes preloaded with real IMCR data, enabling you to adjust forecasts and assumptions to accurately determine the intrinsic value of Immunocore Holdings plc.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 32.3 37.9 33.4 180.9 313.9 454.3 657.4 951.5 1,377.1 1,993.0
Revenue Growth, % 0 17.32 -11.93 441.99 73.53 44.73 44.73 44.73 44.73 44.73
EBITDA -142.4 -129.1 -209.8 -48.3 -65.0 -315.6 -456.8 -661.1 -956.8 -1,384.7
EBITDA, % -440.92 -340.66 -628.64 -26.68 -20.71 -69.48 -69.48 -69.48 -69.48 -69.48
Depreciation 11.6 11.3 9.6 6.7 5.1 90.6 131.1 189.7 274.5 397.3
Depreciation, % 35.89 29.81 28.62 3.71 1.64 19.93 19.93 19.93 19.93 19.93
EBIT -154.0 -140.4 -219.3 -55.0 -70.1 -320.5 -463.8 -671.3 -971.5 -1,406.0
EBIT, % -476.81 -370.47 -657.26 -30.4 -22.35 -70.55 -70.55 -70.55 -70.55 -70.55
Total Cash 93.1 163.2 299.3 418.5 557.0 454.3 657.4 951.5 1,377.1 1,993.0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1.9 2.6 31.3 35.0 77.3
Account Receivables, % 5.73 6.81 93.67 19.33 24.63
Inventories -61.1 -26.6 -23.6 1.2 5.7 -216.8 -313.8 -454.2 -657.4 -951.4
Inventories, % -189.25 -70.28 -70.86 0.65606 1.8 -47.74 -47.74 -47.74 -47.74 -47.74
Accounts Payable 19.8 9.9 12.7 18.2 22.4 129.7 187.8 271.7 393.3 569.2
Accounts Payable, % 61.28 26.17 38.16 10.05 7.14 28.56 28.56 28.56 28.56 28.56
Capital Expenditure -5.4 -3.9 -1.3 -2.8 -6.8 -31.2 -45.2 -65.4 -94.7 -137.0
Capital Expenditure, % -16.66 -10.21 -3.8 -1.53 -2.17 -6.87 -6.87 -6.87 -6.87 -6.87
Tax Rate, % 9.2 9.2 9.2 9.2 9.2 9.2 9.2 9.2 9.2 9.2
EBITAT -126.8 -119.1 -204.7 -51.3 -63.7 -285.0 -412.5 -597.0 -864.0 -1,250.5
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -41.6 -156.7 -225.3 -70.5 -108.0 45.0 -232.6 -336.7 -487.3 -705.2
WACC, % 7.65 7.66 7.7 7.7 7.69 7.68 7.68 7.68 7.68 7.68
PV UFCF
SUM PV UFCF -1,278.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -719
Terminal Value -12,667
Present Terminal Value -8,750
Enterprise Value -10,028
Net Debt -451
Equity Value -9,577
Diluted Shares Outstanding, MM 49
Equity Value Per Share -195.90

What You Will Get

  • Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: Immunocore Holdings plc’s (IMCR) financial data pre-loaded to enhance your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A refined Excel model tailored to meet your valuation requirements.
  • Built for Analysts and Investors: Perfect for testing forecasts, verifying strategies, and increasing efficiency.

Key Features

  • 🔍 Real-Life IMCR Financials: Pre-filled historical and projected data for Immunocore Holdings plc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Immunocore’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Immunocore’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review Immunocore Holdings plc's (IMCR) pre-filled financial data and forecasts.
  3. Step 3: Modify critical inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Watch the DCF model update instantly as you adjust your assumptions.
  5. Step 5: Analyze the outputs and utilize the results for your investment decisions.

Why Choose the Immunocore Holdings plc (IMCR) Calculator?

  • Accuracy: Utilizes real Immunocore financial data for precise calculations.
  • Flexibility: Allows users to easily experiment with and adjust inputs.
  • Time-Saving: Eliminate the need to create a financial model from the ground up.
  • Professional-Grade: Crafted with the expertise and precision expected at the CFO level.
  • User-Friendly: Intuitive interface designed for users of all financial backgrounds.

Who Should Use This Product?

  • Investors: Accurately assess Immunocore Holdings plc’s (IMCR) fair value prior to making investment choices.
  • CFOs: Utilize a professional-grade DCF model for comprehensive financial reporting and analysis.
  • Consultants: Efficiently customize the template for client valuation reports.
  • Entrepreneurs: Acquire knowledge of financial modeling techniques employed by leading biotech firms.
  • Educators: Implement it as a pedagogical resource to illustrate valuation methodologies.

What the Template Contains

  • Pre-Filled DCF Model: Immunocore's financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Immunocore's profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

Es wurden keine passenden Produkte gefunden.